AI Tools Increase Low-Dose CT Lung Nodule Specificity
|
By MedImaging International staff writers Posted on 02 Feb 2021 |

Image: AI identification of lung nodule matches or bests that of trained radiologists (Photo courtesy of iStock)
Combining artificial intelligence (AI) and lung imaging reporting and data system (Lung-RADS) scores can increase CT scan specificity without reducing sensitivity, according to a new study.
Researchers at the University of Saskatchewan (Saskatoon, Canada) conducted a study that performed secondary analysis of a known data set using an AI model developed by Google in 2019, and Lung-RADS classifications from six radiologists. They then compared them to assess a representative cohort of 3,197 baseline low-dose CT screening patients. To ensure the AI algorithm matched the 91% sensitivity level achieved by the providers, the researchers determined a 0.27 AI risk-score threshold, based on a 0-to-1 scale.
The results showed that the AI-informed management strategy achieved sensitivity and specificity of 91% and 96%, respectively, while the average sensitivity and specificity of the six radiologists using only Lung-RADS was 91% and 61%, respectively. Based on the AI management strategy, 0.2% of category 1 or 2 Lung-RADS classifications were upgraded to category 3, and 30% of category 3 or higher classifications were downgraded to category 2. The minimum net cost savings, based on 2019 U.S. Medicare physician fee schedule, was USD 72 per patient screened. The study was published on January 19, 2021, in Journal of the American College of Radiology.
“Using an AI risk score combined with Lung-RADS at baseline lung cancer screening may result in fewer follow-up investigations and substantial cost savings. Specificity could rise by more than fifty percent,” concluded lead author Scott Adams, MD, and colleagues. “Additional research for other AI thresholds could also beneficial, especially for Lung-RADS category 4 nodules. Ultimately, additional investigations could lead to AI algorithms being used in a similar way to what has been suggested for screening mammography.”
Lung-RADS is a quality assurance tool designed to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring. It is modeled on the success of the Breast Imaging Reporting and Data System (BI-RADS), with the primary goal of minimizing variation in the management of CT-detected lung nodules so that screening can be implemented effectively in radiology practices.
Related Links:
University of Saskatchewan
Researchers at the University of Saskatchewan (Saskatoon, Canada) conducted a study that performed secondary analysis of a known data set using an AI model developed by Google in 2019, and Lung-RADS classifications from six radiologists. They then compared them to assess a representative cohort of 3,197 baseline low-dose CT screening patients. To ensure the AI algorithm matched the 91% sensitivity level achieved by the providers, the researchers determined a 0.27 AI risk-score threshold, based on a 0-to-1 scale.
The results showed that the AI-informed management strategy achieved sensitivity and specificity of 91% and 96%, respectively, while the average sensitivity and specificity of the six radiologists using only Lung-RADS was 91% and 61%, respectively. Based on the AI management strategy, 0.2% of category 1 or 2 Lung-RADS classifications were upgraded to category 3, and 30% of category 3 or higher classifications were downgraded to category 2. The minimum net cost savings, based on 2019 U.S. Medicare physician fee schedule, was USD 72 per patient screened. The study was published on January 19, 2021, in Journal of the American College of Radiology.
“Using an AI risk score combined with Lung-RADS at baseline lung cancer screening may result in fewer follow-up investigations and substantial cost savings. Specificity could rise by more than fifty percent,” concluded lead author Scott Adams, MD, and colleagues. “Additional research for other AI thresholds could also beneficial, especially for Lung-RADS category 4 nodules. Ultimately, additional investigations could lead to AI algorithms being used in a similar way to what has been suggested for screening mammography.”
Lung-RADS is a quality assurance tool designed to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring. It is modeled on the success of the Breast Imaging Reporting and Data System (BI-RADS), with the primary goal of minimizing variation in the management of CT-detected lung nodules so that screening can be implemented effectively in radiology practices.
Related Links:
University of Saskatchewan
Latest Radiography News
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
- AI Detects Fatty Liver Disease from Chest X-Rays
- AI Detects Hidden Heart Disease in Existing CT Chest Scans
- Ultra-Lightweight AI Model Runs Without GPU to Break Barriers in Lung Cancer Diagnosis
- AI Radiology Tool Identifies Life-Threatening Conditions in Milliseconds
Channels
MRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read moreMRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read more
AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
Placenta accreta spectrum (PAS) is a life-threatening pregnancy complication in which the placenta abnormally attaches to the uterine wall. The condition is a leading cause of maternal mortality and morbidity... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read more
New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
Medical imaging is central to diagnosing and managing injuries, cancer, infections, and chronic diseases, yet existing tools each come with trade-offs. Ultrasound, X-ray, CT, and MRI can be costly, time-consuming,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







